Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Biotech Stocks Open Lower Shares of Atherogenics Inc. opened down 7.2 percent on the Nasdaq Wednesday following a pre-market report that the drug developer is abandoning further clinical trials of its AGIX-4207 treatment for rheumatoid arthritis.
